ORIC: oricpharma.com Net earnings per share for the last 12 months

Symbol and logo of brand ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals operates as a virtual biopharma, fully outsourcing synthesis and clinical trials to external contractors. The company's rolling annual profit per share illustrates revenue dynamics, where -1.35 represents the current level of the metric. The business focuses on combating drug-resistant tumors. Development relies on venture capital and close partnerships with industry behemoths to create combination therapies.

ORIC (ORIC Pharmaceuticals) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/10/2026

Analytical breakdowns for ORIC Pharmaceuticals

- share price and expert price forecast:
Stock Quotes ORIC Pharmaceuticals|ORIC - Fair Value Consensus
- market capitalization information:
Market Valuation ORIC Pharmaceuticals, Inc.|ORIC - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share ORIC Pharmaceuticals|ORIC - Book Capitalization|Market Value to Book Value Ratio oricpharma.com|ORIC - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital ORIC Pharmaceuticals|ORIC - Long-Term Indebtedness to Equity|Short-Term Debt to Capital ORIC Pharma|ORIC - Company Cumulative Debt|Debt to Book Value ORIC Pharmaceuticals, Inc.|ORIC - Amount of Long-Term Liabilities|Company Short-Term Debts ORIC Pharmaceuticals|Quick Ratio oricpharma.com
- net income and valuation multiples indicators:
ORIC - Company Profit|Future Profit ORIC Pharmaceuticals|ORIC - Company Value to Net Income|Projected Price to Earnings ORIC Pharmaceuticals, Inc.|ORIC - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple ORIC Pharmaceuticals, Inc.|ORIC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ORIC Pharmaceuticals|ORIC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months oricpharma.com|ORIC - Earnings per share increase in current year|Earnings growth forecast for next year ORIC Pharmaceuticals
Basic company analysis:ORIC Pharmaceuticals - ORIC
Manufactured products of ORIC Pharmaceuticals Inc

To isolate the fundamental stability of ORIC Pharmaceuticals (ORIC) from market noise, net earnings per share is utilized, which distributes total income across all securities to determine the real return on each share of the business. An analysis of the rolling year earnings per share confirms the financial efficiency of investments in targeted oncology therapy and the highly qualified staff of biologists developing breakthrough treatments.

Who ORIC Pharmaceuticals competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (exelixis.com)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Enliven Corp|Earnings per share for the last twelve months Relay Therapeutics (RLAY)|NRIX (nurixtx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences)|Net earnings per share for the trailing year Verastem Oncology|Monte Rosa Tx - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Corp|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (Black Diamond Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Therapeutics, Inc. RPTX|Net earnings per share (EPS TTM) PMVP|karyopharm.com - Earnings per share for the last 12 months|Propanc Biopharma - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|Aileron Therapeutics - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics) - Net earnings per share (EPS TTM)